Suven Pharmaceuticals Ltd Q1FY23 consolidated profit higher at Rs. 107.54 crores

Suven Pharmaceuticals Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 349.8322 crores during the period ended June 30, 2022 as compared to Rs. 380.7184 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 107.5421 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 91.6680 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 4.22 for the period ended June 30, 2022 as compared to Rs. 3.60 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 349.8322 crs	₹380.7184 crs	-8.11%
Net Profit	₹107.5421 crs	₹91.6680 crs	17.32%
EPS	₹4.22	₹3.60	17.22%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 349.8322 crores during the period ended June 30, 2022 as compared to Rs.269.5842 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.107.5421 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.105.0831 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.4.22 for the period ended June 30, 2022 as compared to Rs.4.13 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 349.8322 crs	₹269.5842 crs	29.77%
Net Profit	₹107.5421 crs	₹105.0831 crs	2.34%
EPS	₹4.22	₹4.13	2.18%

Shares of Suven Pharmaceuticals Limited was last trading in BSE at Rs. 466.10 as compared to the previous close of Rs. 469.90. The total number of shares traded during the day was 4936 in over 179 trades.

The stock hit an intraday high of Rs. 472.20 and intraday low of 462.15. The net turnover during the day was Rs. 2303436.00.

Source : Equity Bulls

Keywords

SuvenPharmaceuticals Q1FY23 ResultUpdate